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In two preceding papers  (1,  2)  certain phenomena concerning the 
antigenicity and infectivity of Type III pneumococci in rabbits were 
described.  The results of these experiments may be summarized as 
follows: Immunization of rabbits  with Pneumococcus Type III  (1) 
fails, in the great majority of instances, to stimulate the production of 
type-specific antibodies, but is always effective in eliciting antibodies 
reactive with pneumococcus nucleoprotein and R strains derived from 
all types of pneumocoeci.  These results were interpreted as indicating 
that normal rabbits possess  some mechanism whereby, following the 
introduction of Type III organisms into the animal body, the anti- 
genie complex of the bacterial cell is so altered that the  type-specific 
component  is  rendered  ineffective  as  antigen.  Since  Avery  and 
Heidelberger  (3)  have  shown  that  type  specificity  resides  in  the 
soluble  specific  substance  which  is  predominantly  present  in  the 
capsule, it appears  that  this altered antigenicity is the result of an 
injury inflicted upon  the  capsular  substance  of  the  cell.  Further 
evidence in support of this view lies in the fact that Pneumococcus 
Type HI possesses low pathogenicity for rabbits.  Ten out of eleven 
strains of this organism, although highly pathogenic for  white mice 
and possessed of large mucoid capsules (S forms), were found to  be 
avirulent for rabbits in doses of 2 to 5 cc. and sometimes 10 ec. (2). 
Since encapsulation and virulence are generally considered as being 
intimately associated,  it  seems possible  that  the method, whereby 
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rabbits resist Type III infection, rests on the same mechanism which 
is responsible for the destruction of the type-specific antigenicity of 
the cell and that by virtue of the injury inflicted on the capsule of the 
living organism,  virulence is  impaired.  These results  expressed in 
terms of the host imply that rabbits possess a  considerable degree of 
natural  resistance  to  Type  III  infection.  However,  to  attribute 
resistance to natural immunity is merely restating the problem and 
leaves unexplained the mechanism in the body on which it depends. 
In the recovery of normal rabbits from Type III infection the evidence 
indicates that in  this instance,  the factors underlying resistance are 
primarily operative against the capsular component of the cell. 
The results previously referred to have concerned the reaction of 
normal  rabbits.  The  experiments reported  in  this  communication 
deal with immunized rabbits, and the purpose has been to determine 
the presence of active immunity against Type III infection following 
immunization not  only  with  homologous organisms but  also  with 
heterologous  strains,  both  S  and  R  forms,  and  with  solutions  of 
pneumococci.  Others  (7, 8)  have reported that  rabbits  immunized 
with Pneumococcus Type III are actively immune against infection 
with homologous organisms even though specific agglutinins are not 
demonstrable.  These results minimize the r61e which specific anti- 
bodies play in active resistance in the case of Type III infection, and 
Singer and Adler (8) have offered an explanation of this phenomenon 
to which subsequent reference will be made.  It seemed of significance 
to determine if any demonstrable antibody participated in this active 
immunity; consequently the sera of all the experimental animals have 
been tested for both type-specific (anti-S), and species-specific (anti- 
P), antibodies and the results correlated with the presence or absence 
of  effective  resistance. 
Testing for the presence of active immunity necessitates the use of 
virulent  organisms.  Although most of the Type  III  strains  have 
been  found to  possess low initial virulence for normal rabbits,  one 
strain was made highly pathogenic by rapid animal passage.  Conse- 
quently  this  rabbit  virulent  strain  afforded a  means of  testing  for 
increased resistance.  Its virulence was maintained so that  .001 cc. 
always proved fatal and, in most of the experiments, .0001 cc. caused 
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each animal may be considered as receiving usually 10,000 and always 
1000  lethal  doses. 
Methods. 
Antigens.--Heat-killed  cultures,  regardless  of the type or strain employed in 
immunization, were, in each instance, made by the same method.  12 to 14 hour 
plain broth  cultures,  killed by heating  at 56  ° for ½ hour, were  centrifuged and 
resuspended in physiological salt solution in such quantities  that  0.5 cc. of the 
vaccine was equivalent to 1 cc. of original culture. 
The pneumococcus solutions used for immunization were made by two different 
methods.  One solution consisted of nucleoprotein derived from Type II pneumo- 
coccus according to the method described by Avery and Morgan (4).  The other 
solution was made as follows: 6 liters of R~ culture (derived from Type II pneumo- 
coccus) were centrifuged and the bacteria  resuspended in 100 co. of physiological 
salt solution.  0.3 cc. of 10 per cent  sodium  desoxycholate was added,  and  the 
mixture incubated at 37.5°C.  for 2 hours.  At the end of this time stained films 
of the fluid showed a complete dissolution of all formed cells.  The solution was 
then  centrifuged  at  high  speed  to  remove  detritus,  and  the  supernatant  fluid 
filtered  through  a  Berkefeld  V  filter.  The  bacteria-flee  filtrate  was  used  for 
immunization. 
Methods of Immunization.--All  rabbits  receiving  heat-killed  organisms  were 
immunized  according to  the  method  described  by  Cole and  Moore  (5),  which 
consists in alternating for 6 weeks, a week of daily injections of 0.5 cc. of vaccine 
followed by a  week of rest. 
Rabbits  injected with pneumococcus solutions received 0.5  cc. intravenously 
each day for the 1st week and during the 2 other alternate weeks of injection re- 
ceived 1 cc. daily. 
All animals were bled 8 to  10 days after the last injection and the antibody 
content of the sera determined. 
Method of Testing Active Immunity.--As previously stated,  a standard dose of 
1 cc. of culture of the rabbit virulent  strain of Type III was intravenously in- 
jected in each test animal.  .0001  cc. of this culture was usually fatal and .001 co. 
always killed normal rabbits. 
For purposes Of following the course of the blood infection in both immunized 
animals  and  normal  controls,  blood cultures  were  taken  at  frequent  intervals 
according to the method previously used (2).  4 to 6 rabbits in addition to 1 or 2 
controls were tested simultaneously. 
Most of the animals which died were examined post mortem with special refer- 
ence to gross pathological changes in the serous cavities. 
Altogether,  44  rabbits  have  been  tested  for the presence of active 
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coccus Type III.  In addition to animals which, by surviving, demon- 
strated a solid immunity, others were considered as partially immune, 
which, although ultimately succumbing, showed evidence of increased 
resistance by reason of the duration of life, the character of the bactere- 
mia as contrasted with controls, and the presence of localized infection 
found post mortem.  A more detailed consideration of these factors 
will be given in the analysis of the results. 
The  experimental  animals,  depending  upon  the  pneumococcus 
material used for immunization, may be grouped as follows: 
I.  Rabbits immunized with Pneumococcus, Type III. 
II.  Rabbits immunized with Pneumococcus, Type I or II. 
III.  Rabbits immunized with Pneumococcus, R strains. 
IV.  Rabbits immunized with solutions of Pneumococcus. 
Group [.  Rabbits  Immunized  with Type [H Pneumococcus. 
Twelve rabbits belong to this group.  They were chosen from the 
28 rabbits used in the immunization experiments previously reported 
(1).  The strain of Type III used for immunization of these animals, 
although encapsulated, type-specific, and highly pathogenic for mice, 
was avirulent for rabbits in doses of 5 cc.  3 of the 12 possessed type- 
specific agglufinins in low titre (2 of the sera were not reactive beyond 
1:2  dilution and the other was not reactive beyond 1:20  dilution). 
The  sera  of  the  other  9  contained  no  demonstrable  type-specific 
antibodies.  The sera of all  the animals possessed  antiprotein anti- 
bodies,  and  agglutinated R  strains  in  1:160  or  1:320  dilutions of 
serum, 
Of the 3  rabbits whose sera possessed  demonstrable type-specific 
antibodies, 1 survived, 1 lived 7 days and showed evidence of increased 
resistance, 1 died simultaneously with the control.  Of the other 9 
rabbits, 5 survived, 3 lived 11,  16, and 22 days respectively showing 
evidence of increased resistance, 1 died with the control. 
In summary, it may be seen that of the 12 rabbits immunized with 
Type III pneumococcus, 6 survived, 4 showed evidence of increased 
resistance, and 2 died at the same time as the controls.  These results 
expressed in percentage are: 50 per cent survived and, by including 
the partially immune, 83  per cent showed definite evidence of in- 
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Group 1I.  Rabbits Immunized with Type I  or Type II Pneumococci. 
Fifteen rabbits belong to this group; 10 were immunized with Type 
II, 5 with Type I, and all were subsequently infected with Type III. 
The sera of these animals contained homologous type-specific agglu- 
tinins to the usual degree and also antiprotein antibodies agglutinating 
R  pneumococci to  approximately 1:160  dilution of serum.  Of  the 
10 rabbits immunized with Type II, 7 survived, 2 living 6 and 7 days 
respectively, were considered as  possessing  some immunity,  1 was 
unprotected.  Of the 5 rabbits immunized with Type I, 4  survived 
and 1 was unprotected.  The results obtained with rabbits immunized. 
with heterologous type-specific pneumococci may be summarized as 
follows:  11 survived infection with Type III, and 2 showed evidence 
of increased resistance.  Expressed in percentage, 73  per cent sur- 
vived and a total of 86 per cent showed evidence of active immunity. 
Group 111.  Rabbits Immunized with R Forms of Pneumococci. 
Eleven rabbits belong to this group.  5 were immunized with an 
R  strain derived from Type I  pneumococcus (designated R1); 5 with 
an R strain derived from Type II (designated R~); 1 with an R strain 
derived from Type III  (designated R3).  The sera of these rabbits 
contained no type-specific antibodies, but only antiprotein antibodies 
reactive with  R  strains  in  dilutions  of  1:160  to  1:320.  Of  the  5 
rabbits immunized with Ra, 3 survived, 1 lived 6 days with evidence of 
resistance, and 1, living 4 days, was classified as not being immune. 
Of the 5 immunized with R~, 4 survived, and 1 lived 5 days with evi- 
dence of  resistance.  The  1  animal  immunized with  R~  survived. 
The results with the rabbits immunized with non-type-specific, non- 
encapsulated R  strains show that 8 survived, 2 showed evidence of 
increased  resistance,  and  1  was  not  considered  as  immune.  Ex- 
pressed in percentage, 72 per cent survived and a total of 90 per cent 
showed evidence of increased resistance. 
Group  1V.  Rabbits  Immunized  with Solutions  of Pneumococci. 
Six rabbits belong to this group.  The sera of these animals con- 
rained only antiprotein antibodies.  The titre of R  agglutinins ob- 
tained by immunization with purified nucleoprotein (Rabbits 24 and 348  ~M~VNITY  TO P•EVMOCOCCUS  ~UCOSVS (TYPE m).  m 
25 in Table III)  was  1:100.  The antiprotein antibodies present in 
the  sera  of  the  rabbits  immunized with  desoxycholate solution of 
pneumococci (Rabbits 27,  28, 29,  and 30)  agglutinated R  organisms 
in  dilutions  of  1: 1260.  No  type-specific  antibodies  were  demon- 
strable. 
None of these animals showed evidence of increased resistance to 
the amount of culture with which they were infected.  Although 1 
lived 3½ days, blood cultures showed countless organisms (oo) in each 
culture taken later than  18 hours after infection.  Table III shows 
the course of the bacteremia in  this group of animals, which is in 
striking contrast to the blood infection occurring in resistant animals 
(Tables I  and II). 
Analysis of Results.--The  data presented in the foregoing experi- 
ments reveal the interesting fact that of 38 rabbits which had been 
previously immunized with pneumococci 25 survived the intravenous 
injection of living, virulent Type III organisms in amounts at least 
a  thousandfold greater  than  the  dose  invariably  fatal  for  normal 
controls.  A second point of equal interest is the fact that this solid 
immunity against Type III infection may be established by prelimi- 
nary treatment with cells of heterologous types and with the degraded 
R  forms  of  pneumococci.  In  other  words,  this  form  of  active 
immunity is effective in the complete absence of demonstrable type- 
specific antibodies in the serum of the treated rabbits, and appears to 
be unrelated to the variety of pneumococcus used for immunization. 
In  attempting  to  analyze  the  mechanism underlying this  form of 
effective but non-specific resistance recourse was had to the method 
previously described (2) by means of which the course of the infection 
may be followed by observing the intensity and duration of the bac- 
teremia.  The course of the bacteremia in 7 of the infected rabbits is 
given in Table I.  The figures presented in the table are typical and 
representative of the results obtained in the group of animals surviving 
infection, regardless of the variety of pneumococcus used for immuni- 
zation, and are  equally characteristic of  the normal control  group. 
3  of  the  animals  whose  protocols  are  given,  had  been  previously 
immunized with a  rabbit avirulent strain of Type III, 3 others had 
been similarly treated with R  cells derived from heterologous types, 
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Type II.  For purposes of comparison the course of the  bacteremia 
during  the  fatal infection of 2  normal control rabbits  is included in 
the same protocol.  The rapidly fatal septicemia in the non-immune 
animals with progressively increasing and overwhelming numbers of 
organisms constantly in the blood is in striking contrast to  the mild, 
TABLE  I. 
Course of Bacteremia in Immunized Rabbits Surviving Infection with 
Rabbit Virulent Strain of Pneumococcus Type IlL 
(The results given in this protocol are  representative  of 25 rabbits which sur- 
vived.) 
rabbit No  ............  1  2  3  4 
Pneumococcus used for 
immunization 
Time of culture 
15 min. 
2 hrs. 
5  ~c 
12  " 
24 " 
36 " 
48  u 
72  " 
4 days 
5  cc 
6  " 
7  " 
8  ¢c 
9  " 
10  " 
11  " 
Type5  6  strain  8  9 
control  control  .x~  III  strain  strain 
No. of  colonies per unit of blood 
oo 
107 
393 
562 
cO 
D 
oo 
QO 
oo 
ao 
D 
660  164 
2  0 
0  3 
6  0 
18  0 
0  4 
0  23 
0  14 
0  30 
S  7 
4 
7 
2 
4 
1 
0 
S 
261 
12 
5 
9 
38 
72 
4 
0 
29 
14 
6 
2 
3 
0 
0 
0 
3200 
22 
6 
12 
18 
6 
5 
5 
3 
15 
1 
0 
6 
0 
0 
0 
S 
620  119 
0  37 
1  20 
8 
3  216 
10  12 
176  32 
14  4 
342  35 
66  5 
8  6 
6  0 
4  0 
2  0 
0  0 
0  0 
S  S 
S indicates  survival of animal 
D indicates  death of snlmal. 
fluctuating,  but  progressively  decreasing  bacteremia  which  charac- 
terizes  the  course of infection  in  the immunized rabbits.  In many 
instances,  the blood infection in the immune animals may persist for 
several days, the circulating organisms varying in number from time 
to  time before ultimately disappearing.  The non-fatal course of the 
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of  Type  III,  highly  virulent  for  rabbits,  parallels  very  closely  the 
curve  of  the  benign  bacteremia  (2)  which  occurs  in  normal  rabbits 
infected with an S  culture of Type  III, avirulent  for this species.  The 
TABLE  II. 
Course of Bacteremia in Immunized Rabbits Not Surviving Infection with 
Rabbit Virulent Strain of Pneumococcus Type III. 
~abbitNo  ....  10  [  11  12  13  14  15  16  17  18  19  20  21  22 
Pneumococcus used for  Normal  TypelTypelType Type  TI2~e TiYll~e  Normal  R,  Rl  R~ 
immunization  controls  III[ llI[  IlI  III  controls 
Time of culture 
15 min. 
2 hrs. 
5  " 
12  " 
24  u 
36  " 
48  " 
72  " 
4 days 
ao  oo 
*o  3200 
oo 
co 
D  D 
29  168  ,o 
9 i 253  96 
2  406  13 
51  592  24 
8 
4 
251  12 
133  3 
316  8 
184 
15 
22 
90J 
15 
D 
I 
330  1641  ~o 
3  13000  ~ 
3  0  ~ 
38  0  ~  oo 
314  0  o~  D 
0  D 
328  23 
19  14 
42  30 
6  " 
8  ~c 
9  " 
10  " 
11  " 
12  " 
13  " 
14  " 
15  " 
16  " 
17  " 
18  " 
19  " 
20  " 
21  " 
93 
i  116 
i  ° 
I 
I 
I 
i 
i  I 
1 
12 
216 
72 
1500 
D 
35 
21 
1200 
86 
10 
4 
20 
32 
D 
1 
D 
268 4000 
4  28 
3  5 
0  7 
34  2 
103  83 
316  41 
56 !  9 
38  D 
D 
56 
2 ¸ 
3, 
12 
D 
D  indicates death of animal. 
possible  Significance of  the  similarity  in  the  course  of  the  ba~teremia 
in  both  instances  and  its  relation  to  the  mechanism  of  recovery  will 
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Of the 38 rabbits immunized with pneumococci--25 of which com- 
pletely recovered from  virulent  Type III  infection--there were  13 
animals which died.  However, 9 of these may justly be considered 
as having acquired a considerable though ineffective degree of immu- 
nity as a  result of the previous immunization.  These animals lived 
5 to 21 days following infection, whereas the controls all died within 
24  to 36  hours.  As previously stated, all  the experimental animals 
suffered a  massive infection receiving 1 cc.  of the virulent Type III 
culture representing from  1000  to  10,000  minimal lethal doses.  If 
the test had been made less severe by giving smaller infecting doses the 
number of  surviving animals would,  in  all  probability,  have  been 
greater. 
Not only the duration of life but also the degree of the bacteremia 
evidenced the presence of resistance in these non-surviving animals. 
In Table II is given the course of the blood infection in 9 rabbits  as 
estimated by blood cultures taken at frequent intervals.  From the 
table it may be seen that  there is an initial sharp reduction in the 
number of circulating organisms in the resistant animals as contrasted 
with the controls, and that,  although death eventually ensued, the 
blood infection during life ran a moderately low grade and irregular 
course, not unlike that in the surviving rabbits.  Even in 2 animals 
(Nos.  13 and 15), which died within 48 hours, and not tabulated as 
immune, the extent of the bacteremia is markedly less than in the 
controls.  The results indicate that these partially resistant rabbits, 
although not possessing a  solid immunity, were capable of checking 
the infection, either by inhibiting multiplication of the bacteria or by 
actually destroying them.  Still further evidence that the rabbits, in 
which death was delayed, possessed some immunity is brought out by 
the fact that at autopsy, of the 9 examined, 7 suffered from purulent 
pericarditis and pleuritis, a condition not found in the normals, which 
died  of  an  overwhelming septicemia.  Localization  of  infection  is 
generally considered as evidence of partial immunity and this has been 
especially emphasized by Stillman (6)  in experimental production of 
lobar pneumonia.  It seems highly probable that the local inflamma- 
tory processes were at least partially responsible for the fatal outcome. 
In  striking  contrast  to  the  effective resistance  against  Type  III 
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the absence of protection in other animals immunized with solutions 
of  heterologous pneumococci.  The  course  of  the  infection in  this 
group shows that they possessed no resistance, at least against a dose 
as great as 1 cc. of virulent culture.  5 of the 6 rabbits died within 48 
hours and 1 lived 3½ days.  The bacteremia in these animals was olfly 
transiently reduced or entirely unaffected (Table III).  Furthermore, 
none possessed evidence of localization of infection on gross post- 
mortem examination.  It is a striking fact that although these rabbits 
possessed  circulating antiprotein  antibodies  (anti-P)  similar  to  the 
rabbits immunized with whole organisms, no increased resistance was 
TABLE  III. 
Course of Bacteremia in Rabbits Immuni~d with Solutions o/Pneumococci 
and Injected with Rabbit Virulent Strain of Pneumococcus Type HI. 
Rabbit No  ............... 
Material 
for immunization 
15 min. 
2  hrs. 
12  " 
24  ~ 
36  " 
48  " 
72  " 
96  " 
23 
Normal 
control 
1-- 
714 
D 
I 
24  I  25  26 
Pneumococcus  Normal 
nucleoprotein  control  i 
oo  [  ~  oo 
CO  O0  O0 
c:~  i  00  o0 
oo  00  O0 
D  ~  D 
D 
27  28  29  30 
Desoxycholate  solution of 
pneurnococcus (R2) 
o0  ¢O  o0 
175  ~o  115 
426  oo  217 
~o  !  oo  382 
i  D  oo 
oo  I  oo 
oo  D 
oO 
D 
o0 
oO 
D 
D indicates death of animal. 
apparent.  This  is  strongly  suggestive  that  anti-P  antibodies,  in 
themselves, are not significant in this form of active immunity. 
DISCUSSION. 
The experiments reported in the present paper demonstrate that a 
considerable degree of increased resistance against virulent Type III 
pneumococci may  be  stimulated in  rabbits  by  immunization with 
homologous or heterologous type-specific S  pneumococci or with R 
forms  derived  from  them.  The  protection  was  equally  effective 
regardless of the type of pneumococcal cells used for  immunization WILLIAM  S.  TILLETT  353 
(Table IV).  The  exclusion of  a  type-specific  immune  reaction  by 
the  use  of  animals  previously  treated  with  heterologous  S  and  R 
strains, makes it necessary to investigate other factors which might 
afford an explanation of the active immunity.  Singer and Adler  (8), 
in dealing with this problem, concluded that the resistance of immu- 
nized rabbits to Type III was dependent upon changes (Umstimmung) 
in reticulo-endothelial cells with which was associated  the  ability to 
phagocyte the virulent organisms.  Interesting as  their experiments 
were,  they were inconclusive in excluding the possible  influence of 
sessile  specific  antibodies.  However,  when  heterologous  S  and  R 
TABLE  IV. 
Summary of Results in Rabbits Immunized with Homologous or Heterologous 
Pneumococci and Subsequently Infected with Rabbit Virulent Strain of 
Type Ill. 
No. of  Immunized with  rabbits 
12  Type Ill 
[10 Type II 
15  ~  5 Type I 
ll  R 
6  Pneumococcus 
solutions 
Type 
III 
ai~glu- 
tmins 
a+ 
9- 
R 
aggh 
tmin 
-y 
+ 
~h~O. sur- 
vived 
No. re- 
sistant 
not 
surviv- 
ing 
Total 
No. rc 
sistan 
10 
13 
10 
0 
Per 
cent 
86 
90 
0 
N 
not 
sist 
Per 
cent 
17 
14 
10 
100 
pneumococci afford protection, as the present study indicates, type- 
specific  immunological  reactions  are  entirely  eliminated.  Wright 
(9) in a recent publication has reported the results of extensive studies 
on  pneumococcus immunity.  Employing Type  I  pneumococci he 
was able to demonstrate active immunity in rabbits although demon- 
strable  agglutinins were not present  in  the  sera of  the  immunized 
animals.  However, under the conditions of his experiments, he did 
not obtain  increased resistance  to  Type I  by previous injection of 
heterologous organisms and  concluded  that  the  reaction was  type- 
specific. 
Although the experiments reported in this paper have been carried 
out under conditions which entirely exclude type-specific immunity, 354  X~m-UNITY  TO  PNEUMOCOCCUS  MUCOSUS (TYPE  III).  III 
nevertheless, the favorable results obtained under such conditions in 
no  sense minimize the  thoroughly established  significance of  type- 
specific  antibodies  in  protection  against  pneumococcus  infection. 
Their effectiveness in sensitizing virulent homologous  pneumococci  and 
thereby making phagocytosis possible, has been repeatedly observed. 
In seeking for an explanation of the form of non-specific immunity 
against Type III infection on the basis of circulating antibodies it may 
be noted that the sera of all the immune animals possessed antiprotein 
(anti-P)  antibodies.  Antibodies of this character are  reactive with 
the common pneumococcus nucleoprotein (precipitin) and with all R 
strains (agglutinin).  They are not, however, reactive with encapsu- 
lated  type-specific organisms nor do  they confer passive protection 
on  mice  against  virulent  pneumococci.  Consequently it  is  highly 
improbable that they are responsible for the disposition of pathogenic 
Type III organisms.  More direct evidence of the ineffectiveness of 
these antibodies in resistance is brought out by the fact that immuni- 
zation  with  pneumococcus  solutions  (derived  from  heterologous 
organisms) fails to afford protection although the sera of rabbits so 
treated possess anti-P antibodies in high titre.  The one factor which 
all  the  resistant  animals  had  in  common was  immunization with 
formed  pneumococcal cells.  The  nature  of  the  material  used  as 
antigen rather  than  the demonstrable antibody response,  therefore, 
seems to be the significant feature  in stimulating this form of active 
immunity. 
Since  type-specific antibodies have  been excluded, and  since  the 
presence of species antibodies (anti-P) does not furnish an adequate 
explanation for  the resistance  to  Type III,  it  is  necessary to  seek 
further for an understanding of this form of immunity.  In a previous 
paper (2)  it was shown that rabbits  possess a  considerable degree of 
natural  resistance  to  Pneumococcus Type III,  although the strains 
used for injection were S forms and highly pathogenic for mice.  It 
was also shown that the blood infection resulting from the injection of 
these rabbit avirulent  organisms into normal animals is characterized 
by a prolonged course during which the number of circulating bacteria 
vary from time to  time but  eventually disappear.  In  the present 
paper it is shown that the bacteremia occurring in an immune rabbit 
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Consequently it seems possible that  the explanation of acquired re- 
sistance, in this instance, is due not to antibodies which have been 
elicited, but to an increased effectiveness of the mechanism of natural 
resistance.  Wright (9) in his recent publication has offered a similar 
explanation for the active immunity which he obtained and he con- 
sidered  the  difference between  normal  and  immune rabbits  to  be 
quantitative and not qualitative.  However, the emphasis which he 
places  upon  specificity makes  it  necessary  to  assume  that  normal 
rabbits possess  type-specific protective susbtances, a conception which 
Sia (10) previously suggested and more recently (11)  has further em- 
phasized.  The experiments reported in this paper reveal the fact that 
enhanced resistance  to  Type III  pneumococci  may  be  stimulated 
in rabbits by previous injections of any R or S  pneumococcus cells, 
and, according to  the explanation advanced,  is due to an exaltation 
of the same factors which endow normal rabbits with natural resist- 
ance  to  Type  III infection.  Further  experiments  tending to  sub- 
stantiate  this view will be subsequently reported.  If this hypothesis 
proves  correct,  these experiments also  tend  to  show  that, whereas 
intact cells stimulate  the processes of  natural  resistance,  the  same 
material in  solution is  ineffective, although a  similar  antibody  re- 
sponse (anti-P) is elicited in both instances. 
SUMMARY. 
1.  Immunization of rabbits with Type III pneumococci is effective 
in producing active immunity against infection with a virulent strain 
of the homologous organism. 
2.  Immunization of  rabbits with Type I  or II pneumococci, and 
with R forms derived from any of the fixed types, is equally effective 
in producing active immunity against Type III infection. 
3.  Immunization of rabbits with nucleoprotein or with desoxycho- 
iate  solutions of heterologous pneumococci, under the experimental 
conditions described,  appears  to  be  ineffective in producing active 
immunity  against  Type  III  infection. 
CONCLUSIONS. 
Increased resistance against virulent  Type  III pneumococci may 
be stimulated in rabbits by repeated injections of heat-killed cultures 356  IMMUNITY  TO PNEIIMOCOCCUS  MUCOSUS (TYPE III).  III 
of  homologous or  heterologous pneumococci.  This form of active 
immunity,  effective  in  the  absence  of  demonstrable  type-specific 
antibodies and unrelated to the variety of the pneumococcus used for 
immunization, is considered dependent upon an exaltation of the same 
factors which afford normal rabbits  natural  resistance  to  Type III 
pneumococcus. 
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